Allergy Therapeutics plc (AIM ... This product has the potential to redefine the market for allergy products, offering sufferers a safe and effective therapy with a much more convenient treatment ...

In 2019, Lele started Hanimune Therapeutics, a Kensington-based biotech company that has developed allergy preventative products and is currently researching and developing allergy treatment products.

The global allergy treatment market is expected to grow at a CAGR of 6-7% in the coming years, driven by factors such as ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Allergy Therapeutics PLC is an international commercial ... It sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements ...

Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Food Allergy - Pipeline Insight ... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product ...

LONDON - Allergy Therapeutics plc (AIM: AGY), a commercial biotechnology company specializing in allergy vaccines, has granted share options to select members of its management team, including ...